La catena delle opzioni mostra i dati chiave delle opzioni azionarie di One Stop Systems a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per One Stop Systems..

One Stop Systems (NASDAQ:OSS) Azioni, Catena delle Opzioni

One Stop Systems

One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy. The company operates in two reportable segments; OSS designs and manufactures high-performance customized computers and flash arrays, in-flight entertainment & connectivity. Bressner operates as a system integrator with standard and custom all-in-one hardware systems and components for many kinds of industrial environments. The company generates the majority of its revenue from the Bresssner segment.

One Stop Systems Inc

Embla Medical hf

ONESOFT SOLUTIONS INC by OneSoft Solutions, Inc.

OneSoft Solutions Inc

OSS US ESG MINVA ETF

OSSI SHILLER USD ETF

OSSIAM ESG SHIL BAR CAPE GLO SEC ETF

OSSIAM RW COM U ETF

OSSIAM SHILLER BARCLAYS CAPE US USD ETF

OSSIAM US ESG LC UCITS USD A1 ETF

OSSIAM US STEEP ETF

OSSIAM-O.ESG LC S.B.C. UCITS ETF

OSSIAM-WORLD ESG MA.LEAR.UCITS ETF

Piper Sandler analyst Yasmeen Rahimi initiates coverage on Upstream Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPB#NASDAQ">UPB</a>) with a Overweight rating and announces Price Target of $75.

News

Price Target

Initiation

Analyst Ratings

Piper Sandler Initiates Coverage On Upstream Bio with Overweight Rating, Announces Price Target of $75

Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) expanded its multi-year partnership with Telia Company to advance Telia&#8217;s modernization and transformation of telecom and cloud infrastructure <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g41737175/broadcom-and-telia-announce-expanded-partnership-to-further-transform-telco-and-cloud-infrastructu" rel="noreferrer noopener">using VMware&#8217;s product portfolio</a>.
The expanded use of VMware&#8217;s cloud-native architecture will advance Telia&#8217;s automation efforts across network workloads and extend its cloud-native capabilities for key assets.
Krish Prasad, SVP and general manager, VMware Cloud Foundation Division, Broadcom, said, &#8220;We are delighted to enable Telia to continue serving its customers with this VMware software-based platform that includes the needed network and infrastructure orchestration, automation and scale.&#8221;
In addition, Broadcom disclosed significant enhancements to its VeloCloud product line and introduced a new partner program aimed at helping enterprises better support AI and non-<a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g41737271/broadcom-unveils-velorain-an-industry-first-for-robust-ai-networking-beyond-the-data-center" rel="noreferrer noopener">AI workloads and enhance connectivity</a>.
Broadcom&#8217;s latest advancements include the launch of VeloRAIN, an AI/ML-powered architecture designed to boost the performance and security of distributed AI workloads.
It also introduced the high-capacity VeloCloud Edge 4100 and 5100 appliances, which support up to 100Gbps for large enterprises. Additionally, the new Titan Partner Program will help VeloCloud Managed Service Providers grow as enterprise AI adoption accelerates.
Sanjay Uppal, vice president and general manager, VeloCloud Division, Broadcom, stated, &#8220;By harnessing the advanced capabilities of VeloRAIN, AI workloads from distributed inferencing and agentic peer-to-peer applications to upstream heavy RAG transactions will see improved application-based QoE and security across all endpoints of the enterprise.&#8221;
Apart from this, at VMware Explore 2024 in Barcelona, the company disclosed expanded VMware Cloud Foundation (VCF) Advanced Services, new ecosystem <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g41737281/vmware-cloud-foundation-delivers-a-private-cloud-platform-to-accelerate-customers-ai-sovereignty-a" rel="noreferrer noopener">partnerships, and modernization programs</a>.
These initiatives aim to accelerate generative AI application development, enhance cybersecurity, and support sovereign cloud adoption.
Krish Prasad, senior vice president and general manager, VCF Division at Broadcom, commented, &#8220;Through a private cloud platform and portfolio of Advanced Services that are ubiquitous, flexible and secure, we are unlocking the promise of AI in the enterprise, delivering new levels of organizational resilience, and supporting the privacy and digital sovereignty demands of customers around the world.&#8221;
Investors can gain exposure to the stock via Direxion Daily AVGO Bull 2X Shares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVL#NASDAQ">AVL</a>) &nbsp;and&nbsp;Columbia Semiconductor and Technology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEMI#NYSE">SEMI</a>).
Price Action: AVGO shares are up 0.49% at $169.38 premarket at the last check Tuesday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41609022/openai-chooses-broadcom-for-ai-interface-chip-development" target="_blank" rel="noreferrer noopener">OpenAI Chooses Broadcom For AI Interface Chip Development</a></li>
</ul>

Equities

Large Cap

Contracts

AVGO

SEMI

Broadcom Powers Telia's Modernization with VMware, Launches AI-Driven VeloRAIN & More

Piper Sandler analyst Edward Tenthoff initiates coverage on Camp4 Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) with a Overweight rating and announces Price Target of $18.

CAMP

Piper Sandler Initiates Coverage On Camp4 Therapeutics with Overweight Rating, Announces Price Target of $18

BitFuFu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUFU#NASDAQ">FUFU</a>) reported quarterly losses of $(0.03) per share. This is a 50 percent decrease over losses of $(0.02) per share from the same period last year. The company reported $90.34 million in sales this quarter. This is a 47.57 percent increase over sales of $61.22 million the same period last year.

Earnings

FUFU

BitFuFu Q3 EPS $(0.03) Down From $(0.02) YoY, Sales $90.34M Up From $61.22M YoY

Shares of Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) rose sharply in today's pre-market trading after the company reported better-than-expected third-quarter financial results and issued guidance <a href="https://www.benzinga.com/news/earnings/24/11/41730179/palantir-q3-earnings-revenue-beat-eps-beat-customers-up-39-raises-guidance-results-driven-by-unrele">above consensus estimates</a>.
Revenue increased 5% year over year to $3.07 billion, beating the consensus of $3.05 billion. Adjusted EPS of 77 cents surpassed the street view of 68 cents.
Palantir Technologies shares rose 12.9% to $46.75 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Simpple Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPPL#NASDAQ">SPPL</a>) gained 69.5% to $2.00 in pre-market trading after jumping around 269% on Monday.</li>
<li>Bionomics Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNOX#NASDAQ">BNOX</a>) rose 67.6% to $0.3219 in pre-market trading. Bionomics received milestone payment of AUS$1 million from Carina Biotech for BNC101 partnered legacy oncology program.</li>
<li>Avalon GloboCare Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALBT#NASDAQ">ALBT</a>) shares surged 42.4% to $3.19 in pre-market trading after dipping 24% on Monday.</li>
<li>QuinStreet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNST#NASDAQ">QNST</a>) climbed 29.8% to $26.22 in pre-market trading after the company posted upbeat quarterly results and raised its FY25 sales outlook.</li>
<li>Astera Labs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) gained 26.1% to $87.83 in pre-market trading after the company announced better-than-expected quarterly results.</li>
<li>Zyversa Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVSA#NASDAQ">ZVSA</a>) shares rose 15.3% to $2.10 in pre-market trading after falling 5% on Monday.</li>
<li>Vimeo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMEO#NASDAQ">VMEO</a>) gained 15.2% to $5.54 in pre-market trading after the company posted upbeat quarterly results.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) gained 12.6% to $3.12 in pre-market trading.</li>
<li>Alarum Technologies Ltd &#8211; ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAR#NASDAQ">ALAR</a>) gained 16.6% to $14.39 in pre-market trading.</li>
<li>Elevai Labs Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELAB#NASDAQ">ELAB</a>) gained 11.9% to $0.0225 in pre-market trading after the company announced update and extension of pending offer to exchange.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Marqeta, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MQ#NASDAQ">MQ</a>) shares tumbled 38.8% to $3.64 in pre-market trading following weak quarterly sales.</li>
<li>Verrica Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRCA#NASDAQ">VRCA</a>) shares fell 31.4% to $0.98 in pre-market trading after the company posted downbeat quarterly results.</li>
<li>Trio Petroleum Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPET#NYSE">TPET</a>) dipped 24.8% to $0.0960 in pre-market trading after the company announced a 1-for-20 reverse stock split.</li>
<li>Navitas Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) shares fell 19.4% to $2.10 in pre-market trading after the company reported weak third-quarter sales.</li>
<li>Lattice Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) declined 18% to $42.55 in pre-market trading following soft fourth-quarter guidance.</li>
<li>Nft Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MI#NYSE">MI</a>) shares dipped 16.1% to $7.50 in pre-market trading after gaining 9% on Monday.</li>
<li>Vast Renewables Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTE#NASDAQ">VSTE</a>) fell 16.2% to $5.66 in pre-market trading after surging more than 40% on Monday.</li>
<li>Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) fell 15.8% to $103.89 in today's pre-market trading after the company reported worse-than-expected third-quarter financial results and announced it intends to temporarily reduce its quarterly dividend.</li>
<li>Altice USA, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATUS#NYSE">ATUS</a>) fell 14.3% to $2.22 in pre-market trading after the company reported weak third-quarter financial results.</li>
<li>Tactile Systems Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCMD#NASDAQ">TCMD</a>) fell 10.3% to $13.55 in pre-market trading after the company posted weak quarterly sales and lowered FY24 sales forecast.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/41735761/dow-tumbles-250-points-as-investors-brace-for-high-stakes-presidential-election-greed-index-enters-">Dow Tumbles 250 Points As Investors Brace For High-Stakes Presidential Election: Greed Index Enters &#8216;Fear&#8217; Zone</a></li>
</ul>

Pre-Market Outlook

Markets

Movers

Trading Ideas

ALAB

ALAR

ALBT

ATUS

BNOX

ELAB

LSCC

NVTS

PLTR

QNST

SPPL

TCMD

TPET

VMEO

VRCA

VSTE

ZVSA

Why Palantir Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

SBSW

Sibanye Stillwater Q3 Adjusted EBITDA $184M, Up 9% Year-On-Year

Legal

NFLX

Reuters Reported France's PNF Financial Prosecutor Body Has Carried Out Searches Today At Netflix France, Amsterdam Offices, Citing Judicial Source

Phunware Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHUN#NASDAQ">PHUN</a>) experienced a significant surge in its stock price, climbing 10.27% during pre-market trading on Tuesday, as per <a href="https://pro.benzinga.com">Benzinga Pro</a>. 
What Happened: The stock&#8217;s rise occurred just one day before the U.S. Elections. This increase comes as the company remains linked to former President Donald Trump, having managed his 2020 reelection campaign&#8217;s mobile app.
On Friday, Phunware also revealed that Troy Reisner, the<a href="https://www.benzinga.com/markets/equities/24/11/41712003/trump-linked-phunwares-leadership-shuffle-continues-cfo-joins-ceo-in-exit-queue"> Chief Financial Officer</a>, intends to resign between Nov. 15 and Nov. 30. The company emphasized that Reisner&#8217;s departure is not due to any disagreements over business operations or financial practices. A search for a new CFO is underway. Post the announcement, on Monday, PHUN dropped by 10% during pre-market.
During this transition, Interim CEO Stephen Chen will collaborate with Brendhan Botkin, Vice President of Accounting and Financial Reporting, to oversee the roles of principal financial officer and principal accounting officer. Last month, Phunware announced the<a href="https://www.benzinga.com/news/24/10/41521091/trump-linked-phunware-stock-falls-as-ceo-exits-what-you-need-to-know"> resignation of CEO</a> Michael Snavely, with Stephen Chen assuming the role of interim CEO.
See Also: <a href="https://www.benzinga.com/markets/equities/24/11/41734592/palantir-trump-media-hims-hers-health-nxp-semiconductors-and-tesla-why-these-5-stocks-are-on-inv?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">PLTR, DJT, HIMS, NXPI, TSLA: Top 5 Trending Stocks Today</a>
Why It Matters: Phunware&#8217;s stock has been subject to fluctuations, often influenced by its ties to Trump-related ventures. On Oct. 15, Phunware&#8217;s shares surged amid market momentum and its association with <a href="https://www.benzinga.com/news/24/10/41339350/phunware-stock-skyrockets-amid-trump-association-and-market-momentum-whats-going-on">Trump Media &amp; Technology Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>), which launched its Truth+ streaming service. The platform is set to expand with an iOS app and availability on platforms like Apple TV and Amazon Fire.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41734897/elon-musks-doge-department-mention-gives-dogecoin-boost-to-top-of-daily-gainers-memecoin-s?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk&#8217;s &#8216;DOGE&#8217; Department Mention Gives Dogecoin Boost To Top Of Daily Gainers: Memecoin Spikes 6%</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Shutterstock

General

PHUN

Trump-Linked Phunware Stock Is Surging 10% In Pre-Market: What's Going On?

Guidance

Health Care

Fresenius Medical Care Also Reconfirms Its Targets To Achieve An Operating Income Margin Of 10%-14% By 2025

Fresenius Medical Care Confirms Its Outlook For Fiscal 2024 And Expects Revenue To Grow By A Low- To Mid-single Digit Percent Rate, With Operating Income To Grow By 16%-18% Versus Prior Guidance Of Growth By A Mid- To High-teens Percent Rate

Fresenius Medical Care (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMS#NYSE">FMS</a>) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.35 by 108.57 percent. This is a 28.07 percent increase over earnings of $0.57 per share from the same period last year. The company reported quarterly sales of $4.76 billion which missed the analyst consensus estimate of $4.89 billion by 2.67 percent. This is a 3.57 percent decrease over sales of $4.94 billion the same period last year.

Fresenius Medical Care Q3 2024 Adj EPS €0.73 May Not Be Comparable To €0.35 Estimate, Sales €4.76B Miss €4.89B Estimate

Alex Karp, CEO of Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) has cautioned that Europe could face ruin if it does not adopt <a href="https://www.benzinga.com/topic/artificial-intelligence">artificial intelligence (AI) innovation</a>.
What Happened: &#8220;As America once again forges ahead, our allies and partners in Europe are being left behind,&#8221; Karp stated in a letter to shareholders on Monday.
His warning came as <a href="https://www.benzinga.com/news/earnings/24/11/41730179/palantir-q3-earnings-revenue-beat-eps-beat-customers-up-39-raises-guidance-results-driven-by-unrele">Palantir&#8217;s business growth accelerates</a>, surpassing expectations due to the robust demand for advanced AI technologies from&nbsp;U.S. government and commercial customers.
The company&#8217;s revenue in the&nbsp;last quarter reached a record&nbsp;$726 million,&nbsp;a 30% increase from the&nbsp;same period last year.
Palantir&#8217;s year-over-year revenue growth rate&nbsp;has increased over the past&nbsp;six quarters, rising from 13%&nbsp;in the second quarter of 2023 to 30% in the third quarter of 2024.
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/10/41663190/openai-rolls-out-chatgpt-search-google-shares-slide?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">OpenAI Rolls Out ChatGPT Search, Google Shares Slide</a>
In his letter, Karp attributed this growth to&nbsp;early and decades-long investment in&nbsp;technical infrastructure, which is now making large language models valuable to large enterprises.
Palantir has also joined the S&amp;P 500, a goal many thought was fanciful. The company&#8217;s entry into the index was&nbsp;made possible by the strength&nbsp;of its&nbsp;business and expanding demand for&nbsp;its software, he stated.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: Karp&#8217;s warning to Europe comes in the wake of Palantir&#8217;s record-breaking Q3 2024 results, which were driven by an &#8220;unrelenting AI demand that won&#8217;t slow down.&#8221;
The U.S. market remains the&nbsp;core of Palantir&#8217;s business, where institutions have responded&nbsp;most rapidly to the promise&nbsp;of AI.
The release of Palantir&#8217;s&nbsp;newest platform, AIP, has transformed&nbsp;the business, with U.S. revenue reaching $499 million in the third quarter, a 44% increase&nbsp;compared to the same period&nbsp;a year earlier.
Wedbush analyst Dan Ives referred to Palantir as the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41732827/messi-of-ai-wall-street-analyst-gushes-over-robust-earnings-from-palantir">&#8220;Messi of AI&#8221; following the company&#8217;s</a> robust earnings. The company&#8217;s customer count grew 39%, and it raised its full-year outlook across all metrics.
Palantir&#8217;s AI gamble has also paid off, with one customer <a href="https://www.benzinga.com/markets/equities/24/11/41734875/palantirs-ai-gamble-pays-off-as-customer-revenue-from-single-customer-jumps-12x-in-under-8-month">increasing its annual recurring revenue twelvefold</a> in less than eight months after implementing the company's AI platform.
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41702294/apple-begins-shifting-iphone-17-production-in-india-cooks-china-optimism-and-more-this-week-in-apple?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Apple Begins Shifting iPhone 17 Production In India, Cook&#8217;s China Optimism, And More: This Week In Appleverse</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Global

Tech

Palantir CEO Alex Karp Warns Europe Risks Doom Without AI

Outlook
In the Stimulation Services segment, the Company anticipates pricing and activity to decline in the fourth quarter. Due to our integrated model and prudent cost management, we are able to navigate cyclicality without sacrificing service and asset quality. Based on ongoing dialogue with operators we anticipate a recovery in activity in 2025 as compared to the fourth quarter of 2024, and we continue to field new inbound requests for additional integrated fleet deployments with the highest demand for electric and Tier 4 dual fuel or DGB technologies. Today, approximately 72% of our active fleets include e-fleet or natural gas-capable equipment.
The Proppant Production segment started to see incremental improvement as we moved through the third quarter, although natural gas-directed activity was subdued and West Texas remains highly competitive. We anticipate that pricing and volumes in the fourth quarter will be impacted by weaker demand. We continue to actively manage operating costs to partially mitigate the impact of lower profitability. We expect a recovery in activity in 2025 relative to the fourth quarter, with a more pronounced potential improvement in oil-levered regions.

ACDC

ProFrac Anticipates Decline In Stimulation Services And Proppant Production Segments In Q4 2024, With Recovery Expected in 2025

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk said on Monday that the company is not considering building a phone, refuting rumors.
What Happened: &#8220;No, we are not doing a phone,&#8221; Musk <a href="https://www.youtube.com/watch?v=7qZl_5xHoBw">said</a> in a podcast with Joe Rogan published on Monday. However, it is not because the company can&#8217;t do it, the CEO said. 
&#8220;We could do a phone since like the operating system in Tesla &#8211; it&#8217;s Linux-based &#8211; but we have written a massive amount of software on top of that. So probably Tesla is in a better position to create a new phone that&#8217;s not Android or iPhone than maybe any company in the world but it is not something we want to do unless we have to,&#8221; Musk said.
The company will have to make a phone if Apple or Google start censoring apps or acting like &#8220;gatekeepers,&#8221; the CEO added.
Tesla currently has its &#8220;plate full&#8221; with its efforts into electric vehicles, enabling autonomous driving, and robotics, Musk said while adding that making a phone would be &#8220;a huge pain the ass.&#8221;
Why It Matters: Musk first hinted at making a phone in November 2022, following his acquisition of Twitter, now rebranded as&nbsp;X, amidst uncertainty about the microblogging platform&#8217;s&nbsp;status on mainstream app stores.
Musk in June gave mixed signals about the company&#8217;s plans to make a phone. One day he announced in a live stream on X that Tesla was not going to make a phone.
Two days later, the CEO said that his tech company X manufacturing a phone running on a custom open-source operating system in partnership with another smartphone maker is "<a href="https://www.benzinga.com/news/24/06/39265691/a-day-after-shutting-down-tesla-phone-rumors-elon-musk-says-it-is-not-out-of-the-question" target="_blank" rel="noreferrer noopener">not out of the question</a>."
Musk <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/06/39306037/tesla-bull-adam-jonas-thinks-tesla-will-make-a-phone-elon-musk-hopes-it-wont-be-nee">later clarified</a> that Tesla could make a phone but he hopes that it is not &#8220;needed.&#8221;
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41736208/gm-crosses-300k-ev-deliveries-in-us-since-2016-but-its-still-over-40-lower-than-teslas-sales-in-the" target="_blank" rel="noreferrer noopener">GM Crosses 300K EV Deliveries In US Since 2016, But It's Still Over 40% Lower Than Tesla's Sales In The First 9 Months Of 2024</a></li>
</ul>
Photo courtesy: Shutterstock

TSLA

Elon Musk Rejects Rumors Of A Tesla Phone, But Says The EV Giant Will Have To Make One If This Happens

<a href="https://www.nytimes.com/2024/11/05/us/politics/dixville-notch-election-vote-results.html">https://www.nytimes.com/2024/11/05/us/politics/dixville-notch-election-vote-results.html</a>
&nbsp;

Election Day Begins With Dixville Notch Midnight Vote - It's a Harris-Trump Tie In 6 Vote Tally

ProFrac Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACDC#NASDAQ">ACDC</a>) reported quarterly sales of $575.300 million which beat the analyst consensus estimate of $560.713 million by 2.60 percent. This is a 0.19 percent increase over sales of $574.200 million the same period last year.

ProFrac Holding Q3 Sales $575.300M Beat $560.713M Estimate, Net loss $43.5M Compared To Net Loss Of $17.9M YoY

Macro Economic Events

Econ #s

Economics

U.K. Composite Purchasing Managers' Index For October 51.8 Vs. 51.7 Est.; 52.6 Prior

U.K. Services Purchasing Managers Index For October 52.0 Vs. 51.8 Est.; 52.4 Prior

Wedbush analyst Yun Zhong assumes MoonLake (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLTX#NASDAQ">MLTX</a>) with a Outperform rating and lowers Price Target of $73.

MLTX

Wedbush Assumes MoonLake at Outperform, Lowers Price Target of $73

Wedbush analyst Yun Zhong initiates coverage on Rezolute (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RZLT#NASDAQ">RZLT</a>) with a Outperform rating and announces Price Target of $12.

RZLT

Wedbush Initiates Coverage On Rezolute with Outperform Rating, Announces Price Target of $12

Warning: OSS is at high risk of performing badly

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
The stock market rally has been showing no sign of stopping, and while most of it has been driven by Big Tech, it is worth looking into some little-known <a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a>. These stocks usually see huge breakouts and trade at big premiums during bullish rallies. We haven&rsquo;t seen that happen across most penny stocks just yet, but I think it&rsquo;s a good reason to buy up some high-potential names if you are willing to stomach the risks.



Of course, many of these penny stocks are more than just short- to mid-term plays. Most of these up-and-coming firms have huge growth runways, and analysts expect explosive growth over the next decade. If they execute as expected, I believe it is possible that they could turn a $10k investment into something life-changing. Let&rsquo;s take a look!



<h2>OptiNose (OPTN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/10/droplet-test-tube-biotech-1600-3-300x169.jpg" alt="Photo of test tubes and droplet with purple and reddish-orange sunset visual effect, representing biotech"><div>Source: shutterstock.com/Romix Image</div></div>OptiNose (NASDAQ:<a href="https://investorplace.com/stock-quotes/optn-stock-quote/">OPTN</a>) is a specialty pharmaceutical company focused on developing products for patients with diseases treated by otolaryngologists and allergists. I&rsquo;ve been closely watching this little-known penny stock, and I believe it could be a potential hidden gem for risk-tolerant investors.



Their lead product, XHANCE, has shown strong efficacy in treating chronic sinusitis, which, according to their market research, is a key driver of prescribing behavior.



OptiNose is admittedly a speculative bet, but I think the potential payoff could be substantial. The stock has been stuck trading around the $1 level for over a year, but with these promising developments, I wouldn&rsquo;t be surprised to see a breakout if they can execute well.



What I particularly like about OptiNose is its solid and rapidly growing sales base. Analysts are projecting revenue to skyrocket from <a href="https://seekingalpha.com/symbol/OPTN/earnings/estimates" target="_blank">$92 million in 2024 to $342 million by 2028</a>, with profitability expected by 2026.



<div><a href="https://investorplace.com/wp-content/uploads/2024/07/chart-9.png"><img width="1200" height="628" src="https://investorplace.com/wp-content/uploads/2024/07/chart-9.png" alt="penny stocks: OptiNose operating profits"> Click to Enlarge</a><div>Source: Chart courtesy of <a href="https://GuruFocus.com">GuruFocus.com</a></div></div>If everything goes according to plan, the stock is trading at just 3 times 2027 earnings estimates right now.



Of course, the key question is whether their growth plans will play out as hoped. Biotech and pharma startups are always a risky bet. But OptiNose seems to have weathered the worst and has a strong foundation upon which to build. This beaten-down stock could be a hidden multibagger in the making. Just be sure to do your own diligence.



<h2>Unusual Machines (UMAC)</h2>



<div><img width="300" height="165" src="https://investorplace.com/wp-content/uploads/2019/04/dronesmsn-300x165.jpg" alt=""><div>Source: Shutterstock</div></div>Unusual Machines (NYSEMKT:<a href="https://investorplace.com/stock-quotes/umac-stock-quote/">UMAC</a>) manufactures drones and drone components. I&rsquo;m very bullish on drone startups like Unusual Machines. There simply aren&rsquo;t enough of these companies in the U.S. right now, especially ones focused on producing inexpensive military drones for reconnaissance and combat purposes.



Most of those cheaper military drones are currently mass-produced in China and Russia. Meanwhile, the U.S. relies on a handful of giant defense contractors making very expensive drones. I believe this supply chain vulnerability is becoming increasingly apparent to governments worldwide. They&rsquo;re scrambling to ink deals with promising upstart drone makers to diversify their sources.



That&rsquo;s where Unusual Machines comes in. Sure, with just <a target="_blank" href="https://www.stocktitan.net/news/UMAC/">$619,000 in sales</a> (the sales were made in just 45 days) last quarter, it&rsquo;s tiny and unprofitable. However, after a recent $5 million IPO and acquiring key operating units like Fat Shark and Rotor Riot, this Red Cat Holdings (NASDAQ:<a href="https://investorplace.com/stock-quotes/rcat-stock-quote/">RCAT</a>) spinoff has big potential, in my view. Management is moving fast to start churning out NDAA-compliant drone parts from its new Orlando headquarters.



If it can secure those critical &ldquo;Blue UAS&rdquo; certifications soon, lucrative government contracts could follow and really jumpstart growth. Of course, this is an extremely speculative play. I&rsquo;m banking on a rosy future that may not materialize. UMAC is only suitable if you seriously want to turn $10k into a million and take on the risks that come with it.



<h2>High Tide (HITI)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/04/cannabis-stocks1600-3-300x169.png" alt="scientist checking organic hemp wild plants in a cannabis weed commercial greenhouse. Concept of herbal alternative medicine, cbd oil, pharmaceutical industry. Cannabis stocks, FLGC stocks"><div>Source: Chokniti-Studio / Shutterstock.com</div></div>High Tide (NASDAQ:<a href="https://investorplace.com/stock-quotes/hiti-stock-quote/">HITI</a>) operates as a retail-focused cannabis company. I covered this little-known penny stock over a year ago, and it&rsquo;s already up by a whopping 80% since then, but I believe High Tide still has substantial upside potential. High Tide generated <a target="_blank" href="https://www.tipranks.com/news/company-announcements/high-tide-achieves-record-q2-financial-milestones">9.4 million CAD in free cash flow in Q2</a>, more than the prior two quarters combined. It&rsquo;s a rare gem in the cannabis space that isn&rsquo;t burning cash and is on the cusp of sustained profitability.



Once High Tide firmly establishes consistent earnings and accelerates its expansion, I expect this stock could deliver multibagger returns from current levels based solely on the Canadian market opportunity. However, the real game-changer would be U.S. federal cannabis legalization. High Tide already has a footprint in the U.S. but operates with restraints.



<div><a href="https://investorplace.com/wp-content/uploads/2024/07/chart-10.png"><img width="1226" height="741" src="https://investorplace.com/wp-content/uploads/2024/07/chart-10.png" alt="High Tide sales by region chart"> Click to Enlarge</a><div>Source: Chart courtesy of <a href="https://GuruFocus.com">GuruFocus.com</a></div></div>If it can replicate its Canadian success in a market 10 times larger, this under-the-radar stock could turn a $10k investment into something much more meaningful.



<h2>Blackline Safety (BLKLF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/fr_firstindustrial1600-300x169.png" alt="Back View of the Head of the Project Holds Laptop and Discussing Product Details with Chief Engineer while They Walk Through Modern Factory., FR rents out these spaces in the U.S."><div>Source: Gorodenkoff / Shutterstock.com</div></div>Blackline Safety (OTCMKTS:<a href="https://investorplace.com/stock-quotes/blklf-stock-quote/">BLKLF</a>) is a Canadian industrial safety company that is riding the wave of onshoring and industrialization. Shares have already surged 150% from their late-2022 trough, but I think there&rsquo;s plenty of room for this rebound to run. The stock still trades nearly 40% below its February 2020 peak despite the company being perfectly positioned to capitalize on the manufacturing renaissance in the U.S. and Canada.



As companies bring production closer to home, they must ensure their facilities meet the rigorous safety standards in these markets. That&rsquo;s where Blackline shines. Its connected safety technology is already seeing booming demand, with <a target="_blank" href="https://www.morningstar.com/news/business-wire/20240613677452/blackline-safety-reports-highest-quarterly-revenue-ever-q2-hits-316m-up-31-year-over-year">revenue jumping 31% YOY to a record $31.6 million</a> in Q2.



Blackline achieved this growth while also expanding its gross margins to 57% and slashing its cash burn by 78%. This tells me that as the company scales up to meet the surging need for industrial safety, its bottom line could boom.



So, while Blackline may be under the radar now, I believe it&rsquo;s a hidden gem that won&rsquo;t stay hidden for long.



<h2>Talkspace (TALK)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/01/talkspace-300x169.jpg" alt="The Talkspace (TALK) logo is displayed on a smartphone screen."><div>Source: Ben__Stevens / Shutterstock.com</div></div>Talkspace (NASDAQ:<a href="https://investorplace.com/stock-quotes/talk-stock-quote/">TALK</a>) is a leading virtual behavioral health company that connects individuals with licensed therapists through its platform. While telemedicine stocks were all the rage during the COVID-19 pandemic, Talkspace&rsquo;s shares have been on a wild ride since going public. After a sharp decline, the stock surged nearly 500% from Q1 2023 to Q1 2024 before recently pulling back around 43%. I believe this presents an attractive entry point.



In Q1 2024, Talkspace delivered <a target="_blank" href="https://www.investing.com/news/stock-market-news/earnings-call-talkspace-reports-profitability-in-q1-with-revenue-growth-93CH-3427451">36% YOY revenue growth to $45.4 million</a> and achieved its first quarter of profitability with an $800,000 adjusted EBITDA. Management&rsquo;s execution on expanding covered lives, and driving utilization is clearly paying off. The recent Medicare launch in multiple states offers another significant growth catalyst.



With profits expected in 2025, along with a <a target="_blank" href="https://seekingalpha.com/symbol/TALK/earnings/estimates">projected 26% sales growth</a> in 2024 and 17-20% annual increases thereafter, I see ample room for upside. Talkspace is well-positioned to benefit from powerful tailwinds. This includes the destigmatization of mental health and younger generations preferring to do everything online.



<h2>Kneat.com (KSIOF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/pte_biotech_1600-300x169.png" alt="Medical technology network team meeting concept. Doctor hand working smart phone modern digital tablet laptop computer graphics chart interface, sun flare effect photo, PTE"><div>Source: everything possible / Shutterstock.com</div></div>Kneat.com (OTCMKTS:<a href="https://investorplace.com/stock-quotes/ksiof-stock-quote/">KSIOF</a>) provides software validation solutions for the life sciences industry. The stock has rebounded significantly, up 37% in the past six months alone. I believe Kneat is well-positioned to benefit from the plethora of biotech startups that need validation software to ensure compliance with industry regulations.



In Q1, Kneat&rsquo;s annual recurring revenue <a target="_blank" href="https://financialpost.com/globe-newswire/kneat-announces-record-revenue-for-first-quarter-2024">jumped an impressive 57% to 42.1 million CAD</a>. The gross profit margin expanded from 67% to a robust 74%, while operating expenses grew at a much more modest 17% pace compared to the 77% surge in Q1 2023.



Management noted they are landing major new customer wins across North America, Europe, and Asia, which are fueling the growth. However, the real potential lies in expanding these relationships over time. As Kneat becomes ingrained and trusted within organizations, it can multiply its revenue per customer.



GuruFocus&rsquo; DCF model believes the stock will compound through 2026.



<div><a href="https://investorplace.com/wp-content/uploads/2024/07/chart-11.png"><img width="1200" height="628" src="https://investorplace.com/wp-content/uploads/2024/07/chart-11.png" alt="KSIOF gurufocus price"> Click to Enlarge</a><div>Source: Chart courtesy of <a href="https://GuruFocus.com">GuruFocus.com</a></div></div><h2>One Stop Systems (OSS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/computers1600d-300x169.jpg" alt="a man working on a computer hard drive"><div>Source: Shutterstock</div></div>One Stop Systems (NASDAQ:<a href="https://investorplace.com/stock-quotes/oss-stock-quote/">OSS</a>) designs and manufactures high-performance edge computing systems for AI and other applications. Despite seeing a <a target="_blank" href="https://www.marketbeat.com/stocks/NASDAQ/OSS/earnings/">24.6% YOY revenue decline to $12.65 million</a> in Q1 2024, I believe OSS is poised for a strong rebound as AI takes off.



The company has done a stellar job shifting its focus to the booming defense and commercial markets, especially for AI and machine learning at the edge. CEO Mike Knowles <a target="_blank" href="https://markets.businessinsider.com/news/stocks/one-stop-systems-oss-strong-buy-rating-on-ai-pivot-and-long-term-growth-potential-1033188679">noted</a> OSS has expanded its 5-year pipeline to over $1 billion, with 70% from multi-year platform opportunities that should drive more predictable revenue.



While the near-term upside may be limited as many AI/ML applications are still in development and testing phases, I&rsquo;m confident OSS is very well-positioned for the coming wave. HPC and enterprise computing needs are exploding as AI startups proliferate, and transformative systems like OpenAI&rsquo;s Sora could send demand soaring even higher.



OSS is admittedly a high-risk, high-reward bet in this nascent industry. But for investors willing to stomach the volatility, I believe getting in early on OSS&rsquo;s turnaround story could deliver incredible returns if the AI rally keeps charging ahead in the years to come.



On the date of publication, Omor Ibne Ehsan did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.



On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;
<div>Omor Ibne Ehsan is a writer at InvestorPlace. He is a self-taught investor with a focus on growth and cyclical stocks that have strong fundamentals, value, and long-term potential. He also has an interest in high-risk, high-reward investments such as cryptocurrencies and penny stocks. You can follow him on <a href="https://www.linkedin.com/in/omor-ibne-ehsan-56068022b/">LinkedIn</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/07/7-little-known-penny-stocks-that-can-turn-10k-into-1-million/">7 Little-Known Penny Stocks That Can Turn $10K Into $1 Million</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

7 Little-Known Penny Stocks That Can Turn $10K Into $1 Million

Lake Street analyst Eric Martinuzzi maintained a Hold rating on One Stop Systems (OSS – Research Report) today and set a price target of $3.00. The...

Lake Street Sticks to Its Hold Rating for One Stop Systems (OSS)

One Stop Systems Q2 2024 Earnings Preview

The latest update is out from One Stop Systems (OSS). One Stop Systems, Inc. has released its financial results for the second quarter ending June ...

One Stop Systems Q2 2024 Financial Results Overview

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
One Stop Systems (NASDAQ:<a href="https://investorplace.com/stock-quotes/oss-stock-quote/">OSS</a>) just reported results for the second quarter of 2024.<ul><li>One Stop Systems reported earnings per share of -9 cents. This was below the analyst estimate for EPS of -4 cents.</li><li>The company reported revenue of $13.20 million.</li><li>This was 1.70% better than the analyst estimate for revenue of $12.98 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/oss-stock-earnings-one-stop-systems-for-q2-of-2024/">OSS Stock Earnings: One Stop Systems Misses EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

OSS Stock Earnings: One Stop Systems Misses EPS, Beats Revenue for Q2 2024

One Stop Systems, Inc. (OSS) Q2 2024 Earnings Call Transcript

In a report released today, Eric Martinuzzi from Lake Street assigned a Hold rating to One Stop Systems (OSS – Research Report), with a price targe...

Lake Street Releases a Hold Rating on One Stop Systems (OSS)

In a report released today, Eric Martinuzzi from Lake Street maintained a Hold rating on One Stop Systems (OSS – Research Report), with a price tar...

BLKLF

HITI

KSIOF

OPTN

RCAT

TALK

UMAC

Press Releases

One Stop Systems to Report First Quarter 2024 Financial Results

One Stop Systems Announces Annual Meeting of Shareholders

One Stop Systems Reports Q1 2024 Results

FLYHT Reports First Quarter 2024 Results

One Stop Systems to Report Second Quarter 2024 Financial Results

One Stop Systems Reports Q2 2024 Results

OSS Receives Order for Rugged Enterprise Class Servers to Support U.S. Army

One Stop Systems to Participate at the Lake Street Best Ideas Growth Conference on September 12

OSS Enters into a Cooperative Research and Development Agreement with the U.S. Special Operations Command

Comments

One Stop Systems

One Stop Systems (OSS) Opzioni

One Stop Systems (NASDAQ:OSS) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO